The FDA Just Approved a Filler for Temple Hollowing: What Las Vegas Patients Should Know
Galderma's Restylane Contour now has a green light for a spot most people never think to treat: the temples. Here's what got approved, what the trial data actually says, and why this quiet corner of the face matters more than it seems.
Key takeaways
- In late March 2026, the FDA cleared Galderma's Restylane Contour for correcting temple hollowing in adults over 21, expanding a product previously approved only for cheeks and midface volume loss.
- Company-reported trial data found the large majority of patients were rated as responders at the three month mark, with many still showing improvement out to eighteen months.
- Dermatologists point to the temples as an overlooked area of facial aging that can quietly affect overall balance and brow position, not just the hollow itself.
- This is a new option worth discussing with a licensed injector, not a treatment to self-diagnose; individual anatomy and results vary from person to person.
Figures reflect Galderma's publicly reported clinical trial data submitted with its FDA approval; individual results vary by patient.
A New Approval for an Often-Ignored Area
On March 23, 2026, Galderma announced that the FDA had approved its hyaluronic acid filler Restylane Contour for correcting temple hollowing in adults over the age of 21. Until now, the product carried approvals for cheek augmentation and general midface volume loss, so this marks the first time a filler in that lineup has an official green light for the temple region specifically.
The treatment relies on the brand's OBT and XpresHAn gel technology, engineered to strike a balance between structural support and natural movement under the skin. Injectors can place it using either a fine needle or a cannula, depending on the depth and precision a given patient's anatomy calls for, which the company describes as a dual approach built into this specific approval.
Why the Temples Get Overlooked in the First Place
Most conversations about facial aging start with cheeks, jawlines, or under-eyes. The temples rarely come up, even though volume loss there is common as collagen and fat naturally thin with age. One board-certified dermatologist quoted in coverage of the approval called temple hollowing one of the more underappreciated contributors to how tired or worn a face can start to look.
Part of the reason is structural rather than cosmetic vanity. A hollow temple can subtly pull the whole upper face out of balance, sometimes affecting how supported the brow appears. Another dermatologist noted that restoring temple volume can even lend a gentle lift through the brow and surrounding area, which is why some providers treat this zone as a foundation step rather than an afterthought.
That said, the temple is also considered a technically demanding area to work in, given the blood vessels running close to the surface there. Providers who choose to offer this treatment need a solid working knowledge of that anatomy, which is exactly the kind of thing worth asking about before booking.
What the Company's Trial Numbers Actually Showed
Galderma's submitted data described the large majority of trial participants as treatment responders at the three month checkpoint, with a meaningful share still showing improvement at the eighteen month mark, which is roughly how long the company reports effects lasting for many patients. Investigators evaluating photos separately from patients rated nearly all subjects as improved early on, with that share gradually declining but remaining strong further out.
Patient-reported measures told a similar story: many said they felt more refreshed and less tired-looking well into the follow-up period, and most felt their temples still looked natural rather than obviously treated at the later checkpoints. Reported side effects across the study were described as mild to moderate, with no serious safety concerns flagged.
It's worth being clear about what these numbers mean and don't mean. They come from a controlled trial setting with its own criteria for who qualified to participate, and they describe group averages rather than a guarantee for any one person. How someone's own temples respond depends on their anatomy, skin quality, and how much volume has actually been lost.
What This Means If You're Considering It in Las Vegas
Because this is such a new approval, expect a lag before every med spa in town has hands-on experience with the temple-specific technique, even at practices already familiar with the broader product line. That's a normal part of any new indication reaching the local market and isn't a reason for concern.
There's also a real-world pattern worth mentioning: providers report growing interest in temple and midface volume restoration among patients who've lost facial fullness alongside body weight, including from GLP-1 medications. If that sounds familiar, it's simply more reason to have a real conversation with a licensed injector about your specific face rather than assuming a one-size answer.
- Ask whether your provider has trained specifically on the temple-region technique, not just the product generally.
- Bring up any past experience with cheek or midface filler so your injector understands your baseline anatomy.
- Mention any recent weight changes, since volume loss from the body can show up first in the face.
- Expect a conversation about the needle-versus-cannula approach and why your provider would choose one for your case.
Questions Worth Asking Before Booking a Temple Consult
A new approval is a good excuse to ask sharper questions, whatever treatment ends up being right for you. Here's a starting list for a temple-focused consult in Las Vegas.
- Have you treated temples specifically before?: General filler experience isn't the same as hands-on time in this particular region. Ask directly about their temple-specific caseload.
- Needle, cannula, or both?: This approval covers a dual-depth technique. Ask why your provider would pick one method over the other for your anatomy.
- What's actually causing my temple hollowing?: Aging, genetics, and weight change can all play a role. A good consult starts with figuring out the likely cause, not just the fix.
- How does this interact with other areas I've had treated?: Cheeks, brows, and temples all influence each other visually. Ask how a temple treatment might change the balance of work you've already had done.
- What does realistic follow-up look like?: Ask how long your provider expects results to hold for someone with your skin and history, and when a touch-up conversation might come up.
- What are the known risks for this specific area?: The temple region has notable blood vessels nearby. A thorough provider will walk you through those risks before you book anything.
Frequently Asked Questions
Is Restylane Contour for temples available at Las Vegas med spas now?
The FDA approval landed in March 2026, so availability depends on individual practices getting the product and training in place. It's worth asking your provider directly whether they're offering this specific application yet.
Is temple filler the same as cheek filler?
It uses the same product technology in this case, but the approval and technique are specific to the temple region, which has its own anatomy and considerations separate from cheeks or midface.
How long do results typically last?
The company's reported trial data followed patients out to eighteen months with many still showing improvement, though this is a group average from a study and not a guarantee for any individual.
Do I need this if I've never noticed my temples?
Not necessarily. This is informational news about a new option, not a suggestion that everyone needs temple treatment. A consult with a licensed injector is the right way to figure out if it applies to you.